Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown250%
terminated125%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors

NCT03424512
unknownnot_applicable

Group-based Metacognitive Therapy for Burns and Plastics Patients

NCT04959916
unknownnot_applicable

Group Metacognitive Therapy vs Clinical Management for Depression

NCT03711123
completednot_applicable

A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy

NCT02096484

Clinical Trials (4)

Showing 4 of 4 trials
NCT03424512Not Applicable

Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors

Terminated
NCT04959916Not Applicable

Group-based Metacognitive Therapy for Burns and Plastics Patients

Unknown
NCT03711123Not Applicable

Group Metacognitive Therapy vs Clinical Management for Depression

Unknown
NCT02096484Not Applicable

A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4